Department of Intensive Care Unit, Zhejiang Hospital, No. 12, Lingyin Road, Hangzhou, Zhejiang, 322100, People's Republic of China.
Department of Intensive Care Unit, Dongyang People's Hospital, No. 60, Wuning West Road, Dongyang, Zhejiang, 322100, People's Republic of China.
Crit Care. 2019 Jan 10;23(1):9. doi: 10.1186/s13054-019-2309-9.
The effect of loop diuretic use in critically ill patients on vasopressor support or in shock is unclear. This study aimed to explore the relationship between loop diuretic use and hospital mortality in critically ill patients with vasopressor support.
Data were extracted from the Medical Information Mart for Intensive Care III database. Adult patients with records of vasopressor use within 48 h after intensive care unit admission were screened. Multivariable logistic regression and propensity score matching was used to investigate any association.
Data on 7828 patients were included. The crude hospital mortality was significantly lower in patients with diuretic use (166/1469 vs. 1171/6359, p < 0.001). In the extended multivariable logistic models, the odds ratio (OR) of diuretic use was consistently significant in all six models (OR range 0.56-0.75, p < 0.05 for all). In the subgroup analysis, an interaction effect was detected between diuretic use and fluid balance (FB). In the positive FB subgroup, diuretic use was significantly associated with decreased mortality (OR 0.64, 95% confidence interval (CI) 0.51-0.78) but was insignificant in the negative FB subgroup. In the other subgroups of mean arterial pressure, maximum sequential organ failure assessment score, and lactate level, the association between diuretic use and mortality remained significant and no interaction was detected. After propensity score matching, 1463 cases from each group were well matched. The mortality remained significantly lower in the diuretic use group (165/1463 vs. 231/1463, p < 0.001).
Although residual confounding cannot be excluded, loop diuretic use is associated with lower mortality.
在接受血管加压素支持的危重症患者中,使用袢利尿剂对血管加压素支持或休克的影响尚不清楚。本研究旨在探讨在接受血管加压素支持的危重症患者中,使用袢利尿剂与住院死亡率之间的关系。
从医疗信息集市重症监护 III 数据库中提取数据。筛选出重症监护病房入院后 48 小时内有血管加压素使用记录的成年患者。采用多变量逻辑回归和倾向评分匹配来研究任何关联。
共纳入 7828 例患者。利尿剂使用者的住院死亡率明显较低(166/1469 与 1171/6359,p<0.001)。在扩展的多变量逻辑模型中,利尿剂使用的优势比(OR)在所有六个模型中均具有统计学意义(OR 范围为 0.56-0.75,所有 p<0.05)。在亚组分析中,利尿剂使用与液体平衡(FB)之间存在交互作用。在正 FB 亚组中,利尿剂使用与死亡率降低显著相关(OR 0.64,95%置信区间 0.51-0.78),但在负 FB 亚组中无统计学意义。在平均动脉压、最大序贯器官衰竭评估评分和乳酸水平的其他亚组中,利尿剂使用与死亡率之间的关联仍然显著,且未检测到交互作用。在倾向评分匹配后,每组各有 1463 例病例匹配良好。利尿剂使用组的死亡率仍然显著较低(165/1463 与 231/1463,p<0.001)。
尽管无法排除残余混杂因素,但袢利尿剂的使用与死亡率降低相关。